The transaction marks the latest turn in the fortunes of Passage Bio, one of the companies started by gene therapy pioneer ...
Watertown biotech Remix Therapeutics secures $100 million in private placement financing and will merge with Passage Bio to ...
Passage Bio, the Philadelphia-based gene therapy outfit that launched a strategic review earlier this year after tough feedback from the FDA, has found an exit in an ...
Combined company to operate as Remix Therapeutics and advance Remix’s pipeline of novel small molecule therapies designed to reprogram RNA processing and address disease drivers at their origin ...
Forbes contributors publish independent expert analyses and insights. I write about how fintech is disrupting the financial industry. Writing a Solidity contract should feel as friction-free as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results